HIGH.F CANTOURAGE GROUP SE O.N.
- Market cap
- EUR 57.2M
- P/E
- -
- P/B
- 1.18x
- ROE
- -10.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2023.
Is HIGH.F undervalued?
Graham numberThe Graham number of CANTOURAGE GROUP SE O.N. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CANTOURAGE GROUP SE O.N. fundamental analysis
No fundamental analysis for CANTOURAGE GROUP SE O.N. yet.
CANTOURAGE GROUP SE O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CANTOURAGE GROUP SE O.N.
Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally. The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products. It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is h…
Full company profileCANTOURAGE GROUP SE O.N. financial statements
CANTOURAGE GROUP SE O.N. annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 5.22M | 603K | 23.6M |
| Gross Profit | 1.83M | - | 7.41M |
| Operating Income | -954K | 28.7K | -4.33M |
| EBITDA | -809K | 28.7K | -248K |
| Net Income | -969K | 9.01K | -4.27M |
| EPS | -0.08 | 0.00 | -0.34 |
| Balance Sheet | |||
| Total Assets | 4.87M | 44.8M | 44.2M |
| Total Liabilities | 1.23M | 566K | 4.16M |
| Shareholders' Equity | 3.64M | 44.2M | 40.0M |
| Cash & Short-term Investments | 1.96M | 3.38M | 1.02M |
| Cash Flow | |||
| Capital Expenditure | 0.00 | 0.00 | 0.00 |
| Ratios | |||
| ROE | -26.6% | 0.0% | -10.7% |
| ROA | -19.9% | 0.0% | -9.7% |
| Net Profit Margin | -18.6% | 1.5% | -18.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CANTOURAGE GROUP SE O.N. dividends
CANTOURAGE GROUP SE O.N. has not paid dividends in the last 3 fiscal years.
Who owns CANTOURAGE GROUP SE O.N.
- Insiders 0.00%
- Institutions 0.60%
- Public & others 99.40%
- Shares outstanding 11.9M
CANTOURAGE GROUP SE O.N. company profile
- Company name
- CANTOURAGE GROUP SE O.N.
- Ticker
- HIGH.F
- ISIN
- DE000A3DSV01
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- Feurigstr. 54, Berlin, Germany, 10827
- Phone
- 49 30 4701 350 51
- Website
- cantourage.com
About CANTOURAGE GROUP SE O.N.
Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally. The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products. It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.
CANTOURAGE GROUP SE O.N. management
5- Mr. Philip SchetterCEO & Chairman of Management Board
- Ms. Monique JaqqamCFO & Member of Exceutive Board
- Mr. Bernhard RetzerVP Sourcing and Sales & Member of Executive Board
- Ms. Constanze PelzerVP Quality and Regulatory Affairs & Member of Executive Board
- Mr. Manuel TaverneHead of Investor Relations